SureTrader Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: dshade, Granddadx6
Search This Board:
Last Post: 6/28/2016 12:19:10 PM - Followers: 314 - Board type: Free - Posts Today: 2

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Current Report Filing (8-k) 06/09/2016 04:10:29 PM
ONVO News: Annual Report (10-k) 06/09/2016 04:10:04 PM
ONVO News: Annual Statement of Changes in Beneficial Ownership (5) 05/11/2016 07:55:35 PM
ONVO News: Current Report Filing (8-k) 04/05/2016 08:06:43 AM
ONVO News: Current Report Filing (8-k) 02/08/2016 04:11:41 PM
#9239  Sticky Note Organovo Announces Fiscal Fourth-Quarter and Full-Year 2016 Results; Granddadx6 06/09/16 04:13:57 PM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#9299   As expected. I hope some longs mopped up Granddadx6 06/28/16 12:19:10 PM
#9298   It was just Brexit. Nice green again today. dshade 06/28/16 12:17:05 PM
#9297   June B numbers are in for shorts. And bettyfordallstar 06/27/16 06:58:47 PM
#9296   Looks like a lot more than just Brexit Alvie 06/27/16 04:06:53 PM
#9295   You don't think this is just Brexit RandolRocketman 06/27/16 03:13:16 PM
#9294   Lots of short selling. They don't expect Alvie 06/27/16 03:04:17 PM
#9293   Considering what happened today, we got off bettyfordallstar 06/24/16 11:13:00 PM
#9292   Over $1MIL in shares purchased after the close! BuckeyeStocks 06/24/16 04:20:57 PM
#9291   Will we see an 8K by the 4th RandolRocketman 06/24/16 03:29:10 PM
#9290   ONVO: -.14, -4.06% ONVO hasn't seen $7 in nearly RallyTheMarket 06/24/16 03:28:50 PM
#9289   The 36,700 I saw eod went after hours ddbl_our_buck 06/24/16 11:00:28 AM
#9288   When I say blood bath, I mean market. bettyfordallstar 06/24/16 07:43:49 AM
#9286   I wish I knew but I do not. GLTU/A! Granddadx6 06/23/16 04:11:45 PM
#9285   HOD close with increasing and steady volume and Granddadx6 06/23/16 04:10:45 PM
#9284   Two observations :: volume on the Jan 17 ddbl_our_buck 06/23/16 04:06:07 PM
#9283   There's that 29,600 showing up again on L2 ddbl_our_buck 06/23/16 02:25:39 PM
#9282   Very green again. Nice. dshade 06/23/16 01:30:26 PM
#9281   What is going to happen when news of RandolRocketman 06/23/16 12:55:49 PM
#9280   I like it too! Great recovery off the Granddadx6 06/23/16 12:48:42 PM
#9279   Pps holding up very nicely! Me thinks ddbl_our_buck 06/23/16 12:33:26 PM
#9278   Any guesses on when a new CFO will RandolRocketman 06/21/16 09:26:10 AM
#9277   imo, shes going to 4 as long as bfsingle 06/21/16 08:58:44 AM
#9276   Up nice and steady dshade 06/20/16 12:14:02 PM
#9275   Starting to see cover? Shorts have already covered RallyTheMarket 06/17/16 11:56:01 AM
#9274   I have no idea. I did notice an Granddadx6 06/17/16 10:05:10 AM
#9273   Think we're seeing shorts starting to cover? RandolRocketman 06/17/16 10:02:21 AM
#9272   Largest single retail market purchase I can remember Granddadx6 06/17/16 09:57:36 AM
#9271   I saw that ~210K shares traded for $680K BuckeyeStocks 06/17/16 09:52:10 AM
#9270   ONVO Interest is growing. GLTA! Granddadx6 06/17/16 09:36:38 AM
#9269   3.1761 Up 0.0361 (1.15 %)AS OF RandolRocketman 06/16/16 01:01:15 PM
#9268   Price under $3??? Not in my account PaperLion 06/15/16 02:08:36 PM
#9267   Still 10MM short shares to cover yet, so Alvie 06/15/16 01:42:52 PM
#9266   So they've managed to cover and keep the RallyTheMarket 06/15/16 12:41:45 PM
#9265   Shares Short* 10,213,759 RandolRocketman 06/15/16 12:01:03 PM
#9264   Organovo Collaborates With UCSF Team to Develop 3D kachingpdx 06/13/16 09:05:51 PM
#9263   Shows up on TDA just fine and sp ddbl_our_buck 06/13/16 12:33:17 PM
#9262   I noticed that as well. GL! Granddadx6 06/13/16 12:03:05 PM
#9261   Unfortunately the news about the collaboration with USCF BuckeyeStocks 06/13/16 10:57:15 AM
#9260   I missed the news. Why is this going RallyTheMarket 06/13/16 10:29:46 AM
#9259   STRONG NEWS---ONVO---GLTU/A! Granddadx6 06/13/16 09:03:19 AM
#9258   Organovo Collaborates With UCSF Team to Develop 3D BuckeyeStocks 06/13/16 08:51:49 AM
#9257   Organovo Holdings, Inc. has added a news release BuckeyeStocks 06/13/16 08:50:02 AM
#9256   All those millions short are going to wish RandolRocketman 06/12/16 10:14:52 PM
#9255   Columbine Capital Services, Inc. upgrades ORGANOVO HOLDINGS INC RandolRocketman 06/12/16 10:12:28 PM
#9254   Oh ok perhaps not Michelangelo, but someone a RandolRocketman 06/10/16 11:34:58 PM
#9253   I give up! What did HE say? ddbl_our_buck 06/10/16 10:45:50 AM
#9252   What did he say about a getting back RallyTheMarket 06/10/16 10:35:04 AM
#9251   Higher highs and higher lows. Just the way Granddadx6 06/10/16 09:39:29 AM
#9250   'Solid cadence' of repeat customers - em ddbl_our_buck 06/10/16 05:57:43 AM
#9248   Another 100%+ increase in revenue. Double and double RandolRocketman 06/09/16 11:25:03 PM